Journal Article

The race for antiviral drugs to beat COVID — and the next pandemic

Dolgin, Elie

2021

Overview

Despite dire warnings, a stockpile of ready compounds to fight viral pandemics was sorely lacking. Can drugmakers finally do the right thing? Despite dire warnings, a stockpile of ready compounds to fight viral pandemics was sorely lacking. Can drugmakers finally do the right thing?

• Publisher: Nature Publishing Group UK,Nature Publishing Group
• Subject: 631/154 / 631/326/596 / 631/326/596/4130 / Adenosine Monophosphate - administration & dosage / Adenosine Monophosphate - analogs & derivatives / Adenosine Monophosphate - therapeutic use / Alanine - administration & dosage / Alanine - analogs & derivatives / Alanine - therapeutic use / Animals / Antiviral agents / Antiviral Agents - pharmacology / Antiviral Agents - therapeutic use / Birds - virology / Care and treatment / Clinical Trials as Topic / Coronavirus - classification / Coronavirus - drug effects / Coronavirus Infections - epidemiology / COVID-19 - drug therapy / COVID-19 - virology / Cytidine - administration & dosage / Cytidine - analogs & derivatives / Cytidine - chemical synthesis / Cytidine - therapeutic use / Drug Development - trends / Drug Industry - trends / Epidemics / Europe / Humanities and Social Sciences / Humans / Hydroxylamines - administration & dosage / Hydroxylamines - chemical synthesis / Hydroxylamines - therapeutic use / Indoles - administration & dosage / Indoles - therapeutic use / Influenza, Human - drug therapy / Influenza, Human - virology / Leucine - administration & dosage / Leucine - therapeutic use / multidisciplinary / News Feature / Orthomyxoviridae - drug effects / Pandemics / Pyrrolidinones - administration & dosage / Pyrrolidinones - therapeutic use / Science / Severe Acute Respiratory Syndrome - drug therapy / Severe Acute Respiratory Syndrome - epidemiology / Strategic Stockpile / Testing / United States